AdamCastanoMDMS

Nuclear Cardiology, Non-Invasive Cardiology

Cardiologist, Cardiac Amyloid Specialist

Dr. Castano is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

New York Presbyterian Hospital (Columbia Campus)Fellowship, Cardiovascular Disease, 2013 - 2017
Columbia University Mailman School of Public HealthMS, Statistics, 2014 - 2016
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2010 - 2013
Columbia University Vagelos College of Physicians and Surgeons2010 - 2013
University of Michigan Medical SchoolClass of 2010
Princeton UniversityBA, Molecular Biology, Spanish Literature, 2001 - 2005

PubMed

4 citations
A Virtual Cardiovascular Care Program for Prevention of Heart Failure Readmissions in a Skilled Nursing Facility Population: Retrospective Analysis.
Daniel M Friedman, Jana M Goldberg, Rebecca L Molinsky, Mark A. Hanson, Adam Castano
JMIR Cardio. 2021-06-01
22 citations
Drug Discovery and Development in Rare Diseases: Taking a Closer Look at the Tafamidis Story.
Arianna Burton, Adam Castaño, Marianna Bruno, Steve Riley, Jennifer Schumacher
Drug Design, Development and Therapy. 2021-03-18
73 citations
Unveiling Outcomes in Coexisting Severe Aortic Stenosis and Transthyretin Cardiac Amyloidosis
Hannah Rosenblum, Ahmad Masri, David L. Narotsky, Jeff Goldsmith, Nadira Hamid
European Journal of Heart Failure. 2021-02-01

Drug Reduces Hospitalization, Death from Progressive Form of Heart FailureAugust 27th, 2018
Resurrecting Tc 99m PYP: As Cardiac Amyloidosis Therapies Emerge, an Old Test Gains a New PurposeJuly 16th, 2018